A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Heart Failure
Interventions
DEVICE

WiSE CRT System

The WiSE CRT System is an implantable cardiac system to provide left ventricular (LV) pacing stimulation in conjunction with a co-implanted system that provides right ventricular (RV) stimulation. In combination, the devices deliver biventricular (BiV) pacing.

Trial Locations (5)

4006

Royal Brisbane and Women's Hospital, Herston

4102

Princess Alexandra Hospital, Woolloongabba

4215

Patients of Gold Coast University Hospital, Southport

4575

Patients of Sunshine Coast University Hospital, Birtinya

4870

Patients of Cairns Base Hospital, Cairns

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EBR Systems, Inc.

INDUSTRY

NCT06561932 - A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT | Biotech Hunter | Biotech Hunter